Milestone Payments Fuel Growth For Formycon In 2023
The Company’s Biosimilar Partnerships Contributed To Its €77.7m Revenue
Formycon has shared its results for 2023, reporting revenue growth and exceeding projections for its working capital, as the company prepares for approvals in the coming year.
